Product Information
CEFTRIAXONE 250 MG VIAL is a generic product labeled by Apotex Corp., priced at $0.8622 per EA under NDC 60505615101. Its NADAC has been published 110 times since Jul 17, 2024.
FDA first approved this application on Jun 29, 2016. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 mg/1
Manufacturer
Apotex Corp.NDC
60505615101
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
2/18/2026
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203702FDA Approved
6/29/2016
TE Code
AP
On Market Since
6/30/2017
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 250 MG VIAL has been published 110 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8622 per EA |
|---|---|
| All-time high | $0.8717 (May 14, 2025) |
| All-time low | $0.7950 (Nov 20, 2024) |
| 52-week high | $0.8622 |
| 52-week low | $0.8410 |
| Median price | $0.8612 |
| Average price | $0.8487 |
| Largest weekly change | -4.4% (Nov 20, 2024) |
| Weeks tracked | 110 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 250 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 250 MG VIAL, manufactured by Apotex Corp., is $0.8622 per EA (NDC 60505615101), effective Aug 19, 2026.
How has the price of CEFTRIAXONE 250 MG VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 250 MG VIAL has held within roughly two percent of its current level. It has been tracked across 110 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 250 MG VIAL?
Since Jul 17, 2024, the NADAC for CEFTRIAXONE 250 MG VIAL has ranged from a low of $0.7950 (Nov 20, 2024) to a high of $0.8717 (May 14, 2025), with a median of $0.8612 per EA.
Are there cheaper alternatives to CEFTRIAXONE 250 MG VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFTRIAXONE 250 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFTRIAXONE 250 MG VIAL?
CEFTRIAXONE 250 MG VIAL (NDC 60505615101) is labeled by Apotex Corp., and CMS classifies it as a generic product.